Microalgae-derived oxylipins decrease inflammatory mediators by regulating the subcellular location of NFκB and...

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Oxylipins (OXLs) are bioactive lipids involved in inflammation resolution, but their mechanisms are unclear.
• Microalgae-derived OXLs show anti-inflammatory potential in inflammatory bowel disease (IBD) models.
• Key OXLs from Chlamydomonas debaryana and Nannochloropsis gaditana were isolated.

Purpose of the Study:

• To investigate the in vitro anti-inflammatory mechanisms of specific microalgae-derived OXLs.
• To elucidate the role of OXLs in regulating pro-inflammatory cytokines and signaling pathways.

Main Methods:

• In vitro assays using THP-1 macrophages and HT-29 colon cells.
• Measurement of cytokine production (IL-1β, IL-6, IL-8) and enzyme expression (iNOS, COX-2).
• Confocal microscopy to analyze NFκB and PPAR-γ signaling pathway activation.

Main Results:

• OXLs (13S-HOTE, 13S-HODE, 15S-HEPE) reduced pro-inflammatory cytokines and iNOS/COX-2 expression.
• OXLs inhibited nuclear translocation of NFκB and promoted PPAR-γ nuclear migration.
• OXLs acted as PPAR-γ agonists, inhibiting NFκB signaling.

Conclusions:

• Microalgae-derived OXLs possess anti-inflammatory properties by modulating NFκB and PPAR-γ pathways.
• These OXLs demonstrate therapeutic potential for inflammatory diseases like IBD.
• Further research into OXLs as anti-inflammatory agents is warranted.